Everolimus Eluting Cobalt Chromium Coronary Stent System
- UID
- MFG/MD/2020/000257_939a64cca209e686bba520344ef7539d_f2e3243db3846f81a9f80c7d1c0c471b
- Device class
- Class D
- Brand name
- 1.Supraflex, 2. Flexilimus, 3. Protolimus, 4. Vactaflex, 5. Supralimus-Flex, 6. Flexilimus Plus, 7. Protolimus Plus, 8. Vactaflex Plus, 9. Supralimus Flex Plus, 10. Aima Plus, 11. Abrax CoCr
- License holder
- Sahajanand Medical Technologies Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- The Everolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic coronary artery disease due to artery lesions with a reference vessel diameter from 2.00 mm to 4.50 mm
Everolimus Eluting Cobalt Chromium Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000257_939a64cca209e686bba520344ef7539d_f2e3243db3846f81a9f80c7d1c0c471b. This device is marketed under the brand name 1.Supraflex, 2. Flexilimus, 3. Protolimus, 4. Vactaflex, 5. Supralimus-Flex, 6. Flexilimus Plus, 7. Protolimus Plus, 8. Vactaflex Plus, 9. Supralimus Flex Plus, 10. Aima Plus, 11. Abrax CoCr. The license holder is Sahajanand Medical Technologies Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.